In the disease cystic fibrosis (CF), pulmonary infection with Pseudomonas aeruginosa is a common clinical complication that determines most morbidity and almost all excess mortality. We postulated that in this disease a defect in Pseudomonas-reactive IgG antibodies may contribute to chronic Pseudomonas infections. Bronchoalveolar lavages were performed upon 13 patients with CF, 7 patients with chronic bronchitis characterized by recurrent Pseudomonas infections, and 4 normal volunteers. The levels of various proteins important to host defenses and proteases were determined; enzyme inhibition studies were performed. CF respiratory immunoglobulin levels were significantly elevated when compared with both normals and patients with chronic bronchitis (P less than 0.05). Albumin and transferrin levels were decreased in the CF lung fluids. CF elastolytic activity was strikingly elevated (means = 6.02 micrograms/mg total protein) and the inhibitory profile suggested such activity resembled a serine-proteinase. Alpha-1-antitrypsin antigenic levels were not altered in CF respiratory fluids. There was a tendency for the lavage IgG to fall as elastase levels rose (r = -0.29). IgG opsonins for two Pseudomonas immunotypes were isolated with affinity chromatography for functional and immunochemical studies. Bacterial phagocytic rates in the presence of these Pseudomonas-reactive IgG opsonins derived from CF lavage fluid were depressed (0.3% uptake/unit time) when compared with similarly titered positive controls (uptake = 1.3%/unit time, P less than 0.001). Additionally, normal pulmonary macrophage intracellular killing of Pseudomonas was severely altered in the presence of opsonins derived from CF respiratory fluids. At some time points, less than 30% of the bacteria were killed. CF IgG opsonins contain a cleavage fragment (100,000 D, 5S sedimentation coefficient) with antigenic determinants similar to the Fab portion of IgG. The presence of such a fragment was inversely correlated with phagocytic functional activity. Intact IgG comprised as little as 18% of the CF lavage fluid specimens. Aliquots of intact human IgG, when mixed with the CF opsonins, augmented Pseudomonas uptake and improved intracellular killing. Conversely, peptide fragments of IgG opsonins, which are proteolytically derived in vitro, duplicated in our system the defect observed with opsonins derived from CF lung fluids; bacterial uptake was inversely related to the concentration of F(ab')2 and to a greater degree, to Fc present in the opsonic mixture. We concluded that IgG respiratory opsonins are fragmented, inhibiting phagocytosis and serving a permissive role in the chronic Pseudomonas pulmonary infection in the disease CF.
R B Fick Jr, G P Naegel, S U Squier, R E Wood, J B Gee, H Y Reynolds
Title and authors | Publication | Year |
---|---|---|
Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis
Lenhart-Pendergrass PM, Malcolm KC, Wheeler E, Rysavy NM, Poch K, Caceres S, Calhoun KM, Martiniano SL, Nick JA |
Microbiology spectrum | 2023 |
Diagnosis and Management of Cystic Fibrosis Exacerbations.
Milinic T, McElvaney OJ, Goss CH |
Seminars in respiratory and critical care medicine | 2023 |
Subversion of the Complement System by Pseudomonas aeruginosa.
Hastings CJ, Syed SS, Marques CNH |
Journal of bacteriology | 2023 |
Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice
Lena Ostermann, Regina Maus, Jennifer Stolper, Lisanne Schütte, Konstantina Katsarou, Srinu Tumpara, Andreas Pich, Christian Mueller, Sabina Janciauskiene, Tobias Welte, Ulrich A. Maus |
JCI Insight | 2021 |
Neutrophil Elastase and Chronic Lung Disease
JA Voynow, M Shinbashi |
Biomolecules | 2021 |
Pseudomonas aeruginosa elastase (LasB) as a therapeutic target
MJ Everett, DT Davies |
Drug Discovery Today | 2021 |
Protein Engineering: Tools and Applications
H Zhao, SY Lee, J Nielsen, G Stephanopoulos |
2021 | |
Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry
C Hu, T Wang, X Zhuang, Q Sun, X Wang, H Lin, M Feng, J Zhang, Q Cao, Y Jiang |
Journal of Translational Medicine | 2021 |
Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
K McQuillan, F Gargoum, MP Murphy, OJ McElvaney, NG McElvaney, EP Reeves |
Frontiers in pharmacology | 2020 |
Targeting airway inflammation in cystic fibrosis
OJ McElvaney, P Wade, M Murphy, EP Reeves, NG McElvaney |
Expert Review of Respiratory Medicine | 2019 |
Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs
S Radivojev, S Zellnitz, A Paudel, E Fröhlich |
International Journal of Pharmaceutics | 2019 |
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
D Dunlea, L Fee, T McEnery, NG McElvaney, E Reeves |
Journal of inflammation research | 2018 |
Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections
S Wang-Lin, J Balthasar |
Antibodies | 2018 |
Adaptation of Staphylococcus aureus to Airway Environments in Patients With Cystic Fibrosis by Upregulation of Superoxide Dismutase M and Iron-Scavenging Proteins
J Treffon, D Block, M Moche, S Reiss, S Fuchs, S Engelmann, D Becher, L Langhanki, A Mellmann, G Peters, BC Kahl |
The Journal of Infectious Diseases | 2018 |
A specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis
OJ McElvaney, C Gunaratnam, EP Reeves, NG McElvaney |
Journal of Cystic Fibrosis | 2018 |
Comparison of fluorescence-based methods to determine nanoparticle uptake by phagocytes and non-phagocytic cells in vitro
M Claudia, Ö Kristin, O Jennifer, R Eva, F Eleonore |
Toxicology | 2017 |
Neuropeptides in Respiratory Medicine
M Kaliner, P Barnes, G Kunkel, J Baraniuk |
2017 | |
Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease
C Margaroli, R Tirouvanziam |
Molecular and Cellular Pediatrics | 2016 |
Measurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled Compounds
E Fröhlich, A Mercuri, S Wu, S Salar-Behzadi |
Frontiers in pharmacology | 2016 |
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
S Chotirmall, M Al-Alawi, T McEnery, NG McElvaney |
Therapeutics and Clinical Risk Management | 2015 |
Development and application of an inhalation bioaccessibility method (IBM) for lead in the PM10 size fraction of soil
N Boisa, N Elom, JR Dean, ME Deary, G Bird, JA Entwistle |
Environment International | 2014 |
Various Approaches to Clinically Related Research Can Yield Helpful Insight. A Personal Perspective
HY Reynolds |
American journal of respiratory and critical care medicine | 2013 |
Kendig & Chernickâs Disorders of the Respiratory Tract in Children
SH Abman |
Kendig & Chernickâs Disorders of the Respiratory Tract in Children | 2012 |
Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis
JD Chalmers, AT Hill |
Molecular Immunology | 2012 |
Immune Responses in Cystic Fibrosis: Are They Intrinsically Defective?
D Ratner, C Mueller |
American journal of respiratory cell and molecular biology | 2012 |
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
AR Hauser, M Jain, M Bar-Meir, SA McColley |
Clinical microbiology reviews | 2011 |
The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency
CM Greene, T Hassan, K Molloy, NG McElvaney |
Expert Review of Respiratory Medicine | 2011 |
The role of proteases, endoplasmic reticulum stress andSERPINA1heterozygosity in lung disease and α-1 anti-trypsin deficiency
CM Greene, T Hassan, K Molloy, NG McElvaney |
Expert Review of Respiratory Medicine | 2011 |
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
B Korkmaz, MS Horwitz, DE Jenne, F Gauthier, D Sibley |
Pharmacological reviews | 2010 |
Molecular cloning, characterization and in vitro expression of SERPIN B1 of bighorn sheep (Ovis canadensis) and domestic sheep (Ovis aries), and comparison with that of other species
R Subramaniam, RP Dassanayake, J Norimine, WC Brown, DP Knowles, S Srikumaran |
Veterinary Immunology and Immunopathology | 2010 |
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
J Cooley, MK Sontag, FJ Accurso, E Remold-O'Donnell |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2010 |
Pathogenesis and clinical manifestations of chronic colonization by Pseudomonas aeruginosa and its biofilms in the airway tract
H Kobayashi, O Kobayashi, S Kawai |
Journal of Infection and Chemotherapy | 2009 |
Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis
AM Morselli-Labate, R Pezzilli |
Journal of Gastroenterology and Hepatology | 2009 |
Clinical challenges in managing bronchiectasis
KW TSANG, D BILTON |
Respirology | 2009 |
Proteases and cystic fibrosis
JA Voynow, BM Fischer, S Zheng |
The International Journal of Biochemistry & Cell Biology | 2008 |
Interfering with extracellular matrix degradation to blunt inflammation
PJ O'Reilly, A Gaggar, JE Blalock |
Current Opinion in Pharmacology | 2008 |
Targeting neutrophil elastase in cystic fibrosis
E Kelly, CM Greene, NG McElvaney |
Expert Opinion on Therapeutic Targets | 2008 |
Antibodies for the treatment of bacterial infections: current experience and future prospects
C Bebbington, G Yarranton |
Current Opinion in Biotechnology | 2008 |
Moraxella -Dependent α 1 -Antichymotrypsin Neutralization: A Unique Virulence Mechanism
T Manolov, TT Tan, A Forsgren, K Riesbeck |
American journal of respiratory cell and molecular biology | 2008 |
Cathepsin-G Interferes with Clearance of Pseudomonas aeruginosa from Mouse Lungs
J Sedor, L Hogue, K Akers, S Boslaugh, J Schreiber, T Ferkol |
Pediatric Research | 2007 |
Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease
JA Park, KB Adler |
Journal of Organ Dysfunction | 2007 |
Bronchiectasis a Comperhensive Review
NA ., HH . |
Trends in Medical Research | 2006 |
Kendig's Disorders of the Respiratory Tract in Children
SH Abman, JM Davis |
Kendig's Disorders of the Respiratory Tract in Children | 2006 |
The Prokaryotes
M Dworkin, S Falkow, E Rosenberg, KH Schleifer, E Stackebrandt |
2006 | |
Principles of Molecular Medicine
MS Runge, C Patterson |
2006 | |
Pathogenesis, etiology and treatment of bronchiectasis
HH AL-Jahdali, AA Shimemeri, N AL-Shirawi |
Annals of thoracic medicine | 2006 |
Human Neutrophil Elastase Induces Hypersecretion of Mucin from Well-Differentiated Human Bronchial Epithelial Cells in Vitro via a Protein Kinase Cδ-Mediated Mechanism
JA Park, F He, LD Martin, Y Li, BN Chorley, KB Adler |
The American Journal of Pathology | 2005 |
Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronicPseudomonas aeruginosa lung infection
DE Woods, A Cantin, J Cooley, DM Kenney, E Remold-O'Donnell |
Pediatric Pulmonology | 2005 |
Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase C{delta}-mediated mechanism
JA Park, F He, LD Martin, Y Li, BN Chorley, KB Adler |
The American Journal of Pathology | 2005 |
Lung Biology in Health and Disease: Cellular and Molecular Mechanisms
E Sapey, R Stockley |
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential | 2005 |
An Immunoproteomic Approach for Identification of Clinical Biomarkers for Monitoring Disease: Application to Cystic Fibrosis
SK Pedersen, AJ Sloane, SS Prasad, LT Sebastian, RA Lindner, M Hsu, M Robinson, PT Bye, RP Weinberger, JL Harry |
Molecular & cellular proteomics : MCP | 2005 |
Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children
IM Balfour-Lynn, U Mohan, A Bush, M Rosenthal |
Archives of disease in childhood | 2004 |
Cystic fibrosis
F Ratjen, G Döring |
The Lancet | 2003 |
Long-term antibiotics in the management of non-CF bronchiectasis—do they improve outcome?
DJ Evans, M Greenstone |
Respiratory Medicine | 2003 |
Chemokines in the Lung: Mechanisms and Consequences
D Riches |
Chemokines in the Lung: Mechanisms and Consequences | 2003 |
Treatment of Severe Small Airways Disease in Children with Cystic Fibrosis
A Jaffe, IM Balfour-Lynn |
Pediatric Drugs | 2002 |
Bronchiectasis
AF Barker |
New England Journal of Medicine | 2002 |
Treatment of Severe Small Airways Disease in Children with Cystic Fibrosis: Alternatives to Corticosteroids
A Jaffe, IM Balfour-Lynn |
Pediatric Drugs | 2002 |
Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled α1-protease inhibitor in cystic fibrosis
M Griese, C Bredow, P Birrer |
Electrophoresis | 2001 |
Phenotype of CF and the effects of possible modifier genes
JD Acton, RW Wilmott |
Paediatric Respiratory Reviews | 2001 |
Inhalation of α1-Protease Inhibitor in Cystic Fibrosis does not affect Surfactant Convertase and Surface Activity
M Griese, C Bredow, P Birrer, A Schams |
Pulmonary Pharmacology & Therapeutics | 2001 |
Chinks in the Armor of the Airway: Pseudomonas Infection in the Cystic Fibrosis Lung
TW Ferkol, DC Look |
American journal of respiratory cell and molecular biology | 2001 |
Interleukin-8 Up-regulation by Neutrophil Elastase Is Mediated by MyD88/IRAK/TRAF-6 in Human Bronchial Epithelium
DE Walsh, CM Greene, TP Carroll, CC Taggart, PM Gallagher, SJ O'Neill, NG McElvaney |
The Journal of biological chemistry | 2001 |
Cystische Fibrose
D Reinhardt, M Götz, R Kraemer, MH Schöni |
2001 | |
Serine proteinase inhibitor therapy in ?1-antitrypsin inhibitor deficiency and cystic fibrosis
G D�ring |
Pediatric Pulmonology | 1999 |
Characterization of immunoglobulin binding factor in sputum from patients with chronic airway diseases
W Ichikawa, F Ogushi, K Tani, K Maniwa, M Kamada, Y Ohmoto, M Sakatani, S Sone |
Respirology | 1999 |
The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease
BE Britigan, MA Railsback, CD Cox |
Infection and immunity | 1999 |
Chronic Lung Disease in Early Infancy
D Riley |
Chronic Lung Disease in Early Infancy | 1999 |
Recombinant Human Monocyte/Neutrophil Elastase Inhibitor Protects Rat Lungs against Injury from Cystic Fibrosis Airway Secretions
DD Rees, RA Rogers, J Cooley, RJ Mandle, DM Kenney, E Remold-O'Donnell |
American journal of respiratory cell and molecular biology | 1999 |
Role of CFTR in Airway Disease
JM Pilewski, RA Frizzell |
Physiological reviews | 1999 |
Molecular Biology of the Lung
RA Stockley |
1999 | |
The Pseudomonas aeruginosa Secretory Product Pyocyanin Inactivates α1 Protease Inhibitor: Implications for the Pathogenesis of Cystic Fibrosis Lung Disease
EI Tuomanen, BE Britigan, MA Railsback, CD Cox |
Infection and immunity | 1999 |
Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease
R Mahadeva, S Stewart, D Bilton, DA Lomas |
Thorax | 1998 |
New treatments in adult cystic fibrosis
D Bilton, R Mahadeva |
Journal of the Royal Society of Medicine | 1997 |
Genetic and Immunologic Aspects of Cystic Fibrosis
BC Hilman |
Annals of Allergy Asthma & Immunology | 1997 |
Hepatocyte growth factor and neutrophil elastase in idiopathic pulmonary fibrosis
S Hojo, J Fujita, T Yoshinouchi, H Yamanouchi, T Kamei, I Yamadori, Y Otsuki, N Ueda, J Takahara |
Respiratory Medicine | 1997 |
New Treatments in Adult Cystic Fibrosis
D Bilton, R Mahadeva |
Journal of the Royal Society of Medicine | 1997 |
The Pediatric Lung
RW Wilmott |
1997 | |
Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lungs of Nonhuman Primates
RW Wilmott, RS Amin, CR Perez, SE Wert, G Keller, GP Boivin, R Hirsch, J Inocencio, P Lu, SF Reising, S Yei, JA Whitsett, BC Trapnell |
Human Gene Therapy | 1996 |
Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation
RA Miller, GT Rasmussen, CD Cox, BE Britigan |
Infection and immunity | 1996 |
Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis
CM Costello, CM O'Connor, GA Finlay, P Shiels, MX FitzGerald, JP Hayes |
Thorax | 1996 |
Effects of Native and Oxidation-Resistant Secretory Leukoprotease Inhibitor on Cystic Fibrosis Sputum: Inhibition of Neutrophil Elastase Activity and of Sputum-Induced Secretion from Porcine Tracheal Submuc
A Schuster, G Hansen, C Zubrod-Eichert, V Wahn |
Pediatric Research | 1996 |
Role of Microbial Proteases in Pathogenesis
H Maeda |
Microbiology and Immunology | 1996 |
Opportunities for the Use of Aerosolized α1-Antitrypsin for the Treatment of Cystic Fibrosis
ED Allen |
Chest | 1996 |
ARDS Acute Respiratory Distress in Adults
TW Evans, C Haslett |
1996 | |
Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation
RA Miller, BE Britigan |
Journal of Clinical Investigation | 1995 |
Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis
AB Lang, UB Schaad, A Rüdeberg, J Wedgwood, JU Que, E Fürer, SJ Cryz |
The Journal of Pediatrics | 1995 |
New perspectives in understanding and management of the respiratory disease in cystic fibrosis
S Suter |
European Journal of Pediatrics | 1994 |
Correlation between specific IgG subclass antibodies toPseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis
T Pressler, ET Jensen, F Espersen, SS Pedersen, N Høiby, C Koch |
Pediatric Pulmonology | 1994 |
Helicobacter pylori
J Calam |
European Journal of Clinical Investigation | 1994 |
Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases
K Oishi, F Sonoda, S Kobayashi, A Iwagaki, T Nagatake, K Matsushima, K Matsumoto |
Infection and immunity | 1994 |
Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: Preliminary observations
SC Aronoff, FJ Quinn, LS Carpenter, WJ Novick |
The Journal of Pediatrics | 1994 |
Pseudomonas aeruginosa Infections in Patients with Cystic Fibrosis: New Immunomodulatory Strategies
A Buret |
Clinical immunotherapeutics | 1994 |
The Role of Neutrophil Elastase in Chronic Inflammation
G Döring |
American journal of respiratory and critical care medicine | 1994 |
Recent Advances in the Treatment of Cystic Fibrosis
RW Wilmott, MA Fiedler |
Pediatric Clinics of North America | 1994 |
Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody
JF Pittet, MA Matthay, G Pier, M Grady, JP Wiener-Kronish |
Journal of Clinical Investigation | 1993 |
Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4
A Buret, M Dunkley, RL Clancy, AW Cripps |
Infection and immunity | 1993 |
Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis
BE Britigan, MB Hayek, BN Doebbeling, RB Fick |
Infection and immunity | 1993 |
α 1 -Proteinase Inhibitor, Elastase Activity, and Lung Disease Severity in Cystic Fibrosis
CM O'Connor, K Gaffney, J Keane, A Southey, N Byrne, S O'Mahoney, MX Fitzgerald |
American journal of respiratory and critical care medicine | 1993 |
Pharmacokinetics of Recombinant Secretory Leukoprotease Inhibitor Aerosolized to Normals and Individuals with Cystic Fibrosis
NG McElvaney, B Doujaiji, MJ Moan, MR Burnham, MC Wu, RG Crystal |
American journal of respiratory and critical care medicine | 1993 |
The Immunoevasive Activities of Pseudomonas aeruginosa : Relevance for Cystic Fibrosis
A Buret, AW Cripps |
American journal of respiratory and critical care medicine | 1993 |
Elevated Levels of Serum Mucin-associated Antigen in Adult Patients with Cystic Fibrosis
CB Robinson, WR Martin, JL Ratliff, PV Holland, R Wu, CE Cross |
American journal of respiratory and critical care medicine | 1993 |
Pseudomonas aeruginosa as an Opportunistic Pathogen
M Campa, M Bendinelli, H Friedman |
1993 | |
Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: Correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis
RG Cowan, GB Winnie |
Journal of Clinical Immunology | 1993 |
Proteases, Protease Inhibitors and Protease-Derived Peptides
JC Cheronis, JE Repine |
1993 | |
Update on Childhood Asthma
MH Schöni, R Kraemer |
1993 | |
Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line
H Nakamura, K Yoshimura, NG McElvaney, RG Crystal |
Journal of Clinical Investigation | 1992 |
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor
NG McElvaney, H Nakamura, P Birrer, CA Hébert, WL Wong, M Alphonso, JB Baker, MA Catalano, RG Crystal |
Journal of Clinical Investigation | 1992 |
Mucosal immunity toPseudomonas aemginosaalginate in cystic fibrosis
SS Pedersen, H Møller, F Espersen, CH Sørensen, T Jensen, N Høiby |
APMIS | 1992 |
Elevation of Plasma Truncated Elastase α1-Proteinase Inhibitor Complexes in Patients with Inflammatory Lung Diseases
J Fujita, H Nakamura, Y Yamagishi, Y Yamaji, T Shiotani, S Irino |
Chest | 1992 |
Biochemistry of Pulmonary Emphysema
C Grassi, J Travis, L Casali, M Luisetti |
1992 | |
Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation
BE Britigan, BL Edeker |
Journal of Clinical Investigation | 1991 |
Respiratory tract colonization withPseudomonas aeruginosa in cystic fibrosis: Correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function
GB Winnie, RG Cowan |
Pediatric Pulmonology | 1991 |
Aerosol α1 -antitrypsin treatment for cystic fibrosis
NG McElvaney, RC Hubbard, P Birrer, RG Crystal, MS Chernick, MM Frank, DB Caplan |
The Lancet | 1991 |
Microbiology of airway disease in patients with cystic fibrosis
PH Gilligan |
Clinical microbiology reviews | 1991 |
Extrinsic and intrinsic determinants of the host response in environmental lung disease
K Anderson, C Mcsharry |
International Journal of Environmental Health Research | 1991 |
GcGlobulin Functions as a Cochemotaxin in the Lower Respiratory Tract: A Potential Mechanism for Lung Neutrophil Recruitment in Cigarette Smokers
JP Metcalf, AB Thompson, GL Gossman, KJ Nelson, S Koyama, SI Rennard, RA Robbins |
American journal of respiratory and critical care medicine | 1991 |
Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch
MF Tosi, H Zakem, M Berger |
Journal of Clinical Investigation | 1990 |
The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion
DB Hornick, RB Fick |
Journal of Clinical Investigation | 1990 |
Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis
JE van Wye, MS Collins, M Baylor, JE Pennington, YP Hsu, V Sampanvejsopa, RB Moss |
Pediatric Pulmonology | 1990 |
IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA
T Pressler, SS Pedersen, F Espersen, N Høiby, C Koch |
Clinical & Experimental Immunology | 1990 |
Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis
M Fegan, P Francis, AC Hayward, GH Davis, JA Fuerst |
Journal of clinical microbiology | 1990 |
IgA subclasses in sputum from patients with bronchiectasis
D Burnett, SL Hill, AR Bradwell, RA Stockley |
Respiratory Medicine | 1990 |
Selective IgG Subclass Deficiencies and Antibody Responses to Pneumococcal Capsular Polysaccharide Antigen in Adult Community-acquired Pneumonia
B Herer, F Labrousse, M Mordelet-Dambrine, A Durandy, C Offredo-Hemmer, O Ekindjian, J Chretien, G Huchon |
American journal of respiratory and critical care medicine | 1990 |
Cystic Fibrosis
RB Moss |
Cystic Fibrosis | 1990 |
Cystic Fibrosis
RB Moss |
Cystic Fibrosis | 1990 |
Cystic Fibrosis
RB Moss |
Cystic Fibrosis | 1990 |
Cystic Fibrosis
RB Moss |
Cystic Fibrosis | 1990 |
IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.
Pressler T, Pedersen SS, Espersen F, Høiby N, Koch C |
Clinical & Experimental Immunology | 1990 |
Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis
M Berger, RU Sorensen, MF Tosi, DG Dearborn, G Döring |
Journal of Clinical Investigation | 1989 |
Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses
I Eichler, L Joris, YP Hsu, JV Wye, R Bram, R Moss |
Journal of Clinical Investigation | 1989 |
Lung humoral response toPseudomonas species
RB Fick |
European Journal of Clinical Microbiology & Infectious Diseases | 1989 |
Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis
GB Winnie, RG Cowan, NA Wade |
The Journal of Pediatrics | 1989 |
Pathogenic potentials of bacterial proteases
H Maeda, A Molla |
Clinica Chimica Acta | 1989 |
Pathogenesis of the Pseudomonas Lung Lesion in Cystic Fibrosis
RB Fick |
Chest | 1989 |
The role of complement in host defense against Pseudomonas aeruginosa
NL Schiller |
Clinical Immunology Newsletter | 1988 |
Immunoglobulin G and Its Function in the Human Respiratory Tract
HY Reynolds |
Mayo Clinic Proceedings | 1988 |
Bacterial Species-dependent Inhibition of Human Granulocyte Elastase
AR Nogare, WC Vial, GB Toews |
American journal of respiratory and critical care medicine | 1988 |
Pulmonary Macrophage Antimicrobial Activity in Canine Endotoxin Shock and Lung Injury
RF Jacobs, DR Dorsey, AF Tryka, DR Tabor |
Experimental Lung Research | 1988 |
Significance of Immunologic Factors in Cystic Fibrosis
B Przyklenk, A Bauernfeind |
Scandinavian Journal of Gastroenterology | 1988 |
Immunologic Aspects of Cystic Fibrosis
G Döring, A Albus, N Høiby |
Chest | 1988 |
Pulmonary Host Defense: Defects That Lead to Chronic Inflammation of the Airway
DB Hornick |
Clinics in Chest Medicine | 1988 |
Pseudomonas aeruginosa and the Airways Disease of Cystic Fibrosis
JS Hata, RB Fick |
Clinics in Chest Medicine | 1988 |
Comparison of live and inactivated influenza vaccine in high risk children
JC King, PA Gross, CR Denning, PF Gaerlan, PF Wright, GV Quinnan |
Vaccine | 1987 |
Candidacidal factors in murine bronchoalveolar lavage fluid
KM Nugent, RB Fick |
Infection and immunity | 1987 |
Penetration of cefotaxime into respiratory secretions
RB Fick, MR Alexander, RA Prince, JE Kasik |
Antimicrobial agents and chemotherapy | 1987 |
Pseudomonas aeruginosa adhesins for tracheobronchial mucin
R Ramphal, C Guay, GB Pier |
Infection and immunity | 1987 |
Why is pseudomonas the colonizer and why does it persist?
R Ramphal, S Vishwanath |
Infection | 1987 |
Host Defense Impairments That May Lead to Respiratory Infections
HY Reynolds |
Clinics in Chest Medicine | 1987 |
Bronchiectasis—New Therapeutic Approaches Based on Pathogenesis
RA Stockley |
Clinics in Chest Medicine | 1987 |
Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions
PJ Ossanna, ST Test, NR Matheson, S Regiani, SJ Weiss |
Journal of Clinical Investigation | 1986 |
Immunologic aspects of surface infections in the lung
P Piedra, PL Ogra |
The Journal of Pediatrics | 1986 |
Regulation of Matrix Accumulation
JJ Jeffrey |
Regulation of Matrix Accumulation | 1986 |
The interaction of Infection and the Adult Respiratory Distress Syndrome
MS Niederman, AM Fein |
Critical Care Clinics | 1986 |
Immunoglobulins in the lung
D Burnett |
Thorax | 1986 |
ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS
HS Auerbach, JA Kirkpatrick, M Williams, HR Colten |
The Lancet | 1985 |
Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide
P Ames, D DesJardins, GB Pier |
Infection and immunity | 1985 |
Respiratory infections may reflect deficiencies in host defense mechanisms
HY Reynolds |
Disease-a-Month | 1985 |